Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-4598

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy ; volume:17 ; number:1 ; day:19 ; month:2 ; year:2018 ; pages:1-15 ; date:12.2018
Molecular cancer ; 17, Heft 1 (19.2.2018), 1-15, 12.2018

Keyword: Krebs
Onkologie

Creator: Soverini, Simona

Contributor: Mancini, Manuela
Bavaro, Luana
Cavo, Michele
Martinelli, Giovanni
SpringerLink (Online service)

DOI: 10.1186/s12943-018-0780-6

URN: urn:nbn:de:1111-201804084420

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:51 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Soverini, Simona
Mancini, Manuela
Bavaro, Luana
Cavo, Michele
Martinelli, Giovanni
SpringerLink (Online service)

Other Objects (12)

Hochschulschrift

Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling

Hochschulschrift

The role of oncogenic Cbl mutants in Kit signaling and myeloid transformation

Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through ?-catenin

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors

Hochschulschrift

Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling

Hochschulschrift

The role of oncogenic Cbl mutants in Kit signaling and myeloid transformation

Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through ?-catenin

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors

Hochschulschrift

Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling

Hochschulschrift

The role of oncogenic Cbl mutants in Kit signaling and myeloid transformation

Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through ?-catenin

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling

The role of oncogenic Cbl mutants in Kit signaling and myeloid transformation

Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through ?-catenin

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors

Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling

The role of oncogenic Cbl mutants in Kit signaling and myeloid transformation

Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through ?-catenin

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors

Oxidation of protein tyrosine phosphatases as an oncogenic event in FLT3-ITD positive acute myeloid leukemia

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia

Mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling

The role of oncogenic Cbl mutants in Kit signaling and myeloid transformation

Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through ?-catenin

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes

Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition

Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors

Related objects

Reset password